Ignite Creation Date:
2024-05-06 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 2:17 PM
Study NCT ID:
NCT05111444
Status:
UNKNOWN
Last Update Posted:
2021-11-08
First Post:
2021-10-27
Brief Title:
Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive HER2 Advanced Gastric or Gastroesophageal Junction GEJ Adenocarcinoma
Sponsor:
Fudan University
Organization:
Fudan University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-27
First Submit QC Date:
October 27 2021
Study First Post Date:
2021-11-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-27
Last Update Post Date:
2021-11-08
Last Update Post Date Type:
ACTUAL